Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RDYthis companyDr. Reddy's Laboratories Limited	$14.97	24×	2.91×	3.05×	13.66×	-0.6%	52.8%	13.8%	12.8%	12.2%	8.1%	3.0%	0.21×	0.73×	12.42×	1.8×	0.7%	5	5.53	3	B+
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
MANKIND.NSMankind Pharma Limited	₹2,668.30	43.28×	5.08×	5.8×	22.97×	-54.4%	43.1%	19.1%	13.4%	11.7%	9.1%	2.3%	0.39×	1.51×	4.27×	1.07×	0.0%	6	6.53	3	B
SUNPHARMA.NSSun Pharmaceutical Industries Limited	₹1,904.50	36.76×	5.05×	7.22×	22.63×	166.9%	55.7%	23.2%	19.6%	13.7%	11.5%	2.2%	0.06×	-0.38×	39.99×	2.82×	0.9%	5	11.54	4	A-
Peer median	—	36.76×	5.05×	5.8×	22.63×	112.4%	43.1%	19.1%	13.8%	11.7%	9.8%	2.3%	0.06×	-0.06×	39.99×	2.82×	0.9%	5	9.92	4	—